TY - JOUR AU - Ahmed, M. AU - Davis, J. AU - Aucoin, D. AU - Sato, T. AU - Ahuja, S. PY - 2010 DA - 2010// TI - Structural conversion of neurotoxic amyloid-[beta]1-42 oligomers to fibrils JO - Nature Struct Mol Biol VL - 17 UR - https://doi.org/10.1038/nsmb.1799 DO - 10.1038/nsmb.1799 ID - Ahmed2010 ER - TY - STD TI - Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s Disease. N Engl J Med. 2014;370:311–21. ID - ref2 ER - TY - STD TI - Englund H, Sehlin D, Johansson AS, Nilsson LN, Gellerfors P, Paulie S, Lannfelt L, Pettersson FE. Sensitive ELISA detection of amyloid-beta protofibrils in biological samples. J Neurochem. 2007;103:334–45. ID - ref3 ER - TY - JOUR AU - Jicha, G. A. PY - 2009 DA - 2009// TI - Is passive immunization for Alzheimer’s disease ‘alive and well’ or ‘dead and buried’? JO - Expert Opin Biol Ther VL - 9 UR - https://doi.org/10.1517/14712590902828285 DO - 10.1517/14712590902828285 ID - Jicha2009 ER - TY - STD TI - Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL. Synaptic targeting by Alzheimer’s-related amyloid oligomers. J Neuroscience. 2004;24:10191–200. ID - ref5 ER - TY - STD TI - Lord A, Gumucio A, Englund H, Sehlin D, Sundquist VS, Söderberg L, Möller C, Gellerfors P, Lannfelt L, Pettersson FE, Nilsson LN. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer’s disease. Neurobiol Dis. 2009;36:425–34. ID - ref6 ER - TY - JOUR AU - Lublin, A. L. AU - Gandy, S. PY - 2010 DA - 2010// TI - Amyloid-β oligomers: possible roles as key neurotoxins in Alzheimer’s disease JO - Mt Sinai J Med VL - 77 UR - https://doi.org/10.1002/msj.20160 DO - 10.1002/msj.20160 ID - Lublin2010 ER - TY - STD TI - Mastrangelo IA, Ahmed M, Sato T, Liu W, Wang C, Hough P, Smith SO. High-resolution atomic force microscopy of soluble Abeta42 oligomers. J Mol Biol. 2006;358:106–19. ID - ref8 ER - TY - STD TI - Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Luthman J, Teplow DB, Younkin, SG, Näslund J, Lannfelt L. The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formation. Nat Neurosci. 2001;4:887–93. ID - ref9 ER - TY - STD TI - O’Nuallain B, Freir DB, Nicoll AJ, Risse E, Ferguson N, Herron CE, Collinge J, Walsh DM. Amyloid β-protein dimers rapidly form stable synaptotoxic protofibrils. J Neurosci. 2010;30:14411–9. ID - ref10 ER - TY - JOUR AU - Paravastua, A. K. AU - Leapmanb, R. D. AU - Yaua, W. M. AU - Tycko, R. PY - 2008 DA - 2008// TI - Molecular structural basis for polymorphism in Alzheimer’s amyloid fibrils JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0806270105 DO - 10.1073/pnas.0806270105 ID - Paravastua2008 ER - TY - STD TI - Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s Disease. N Engl J Med. 2014;370:322–33. ID - ref12 ER - TY - STD TI - Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, Långström B, Almkvist O, Graff C, Nordberg A. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology. 2012;79:229–36. ID - ref13 ER - TY - STD TI - Sehlin D, Englund H, Simu B, Karlsson M, Ingelsson M, Nikolajeff F, Lannfelt L, Ekholm Pettersson F. Large aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugation. PLoS One. 2012;7:e32014. ID - ref14 ER - TY - STD TI - Sehlin D, Hedlund M, Lord A, Englund H, Gellerfors P, Paulie S, Lannfelt L, Pettersson FE. Heavy-chain complementarity-determining regions determine conformation selectivity of anti-Aβ antibodies. Neurodegener Dis. 2011;8:117–23. ID - ref15 ER - TY - STD TI - Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer’s Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7:367–85. ID - ref16 ER - TY - STD TI - Tucker S, Möller C, Tegerstedt K, Lord A, Laudon H, Sjödahl J, Söderberg L, Spens E, Sahlin C, Waara ER, Satlin A, Gellerfors P, Osswald G, Lannfelt L. The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. J Alzheimers Dis. 2015;43:575–88. ID - ref17 ER - TY - JOUR AU - Viswanathan, A. AU - Chabriat, H. PY - 2006 DA - 2006// TI - Cerebral microhemorrhage JO - Stroke VL - 37 UR - https://doi.org/10.1161/01.STR.0000199847.96188.12 DO - 10.1161/01.STR.0000199847.96188.12 ID - Viswanathan2006 ER - TY - STD TI - Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem. 1999;274:25945–52. ID - ref19 ER - TY - JOUR AU - Walsh, D. M. AU - Lomakin, A. AU - Benedek, G. B. AU - Condron, M. M. AU - Teplow, D. B. PY - 1997 DA - 1997// TI - Amyloid β-protein fibrillogenesis JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.35.22364 DO - 10.1074/jbc.272.35.22364 ID - Walsh1997 ER - TY - JOUR AU - Walsh, D. M. AU - Selkoe, D. J. PY - 2004 DA - 2004// TI - Deciphering the molecular basis of memory failure in Alzheimer’s disease JO - Neuron VL - 44 UR - https://doi.org/10.1016/j.neuron.2004.09.010 DO - 10.1016/j.neuron.2004.09.010 ID - Walsh2004 ER - TY - JOUR AU - Yu, X. AU - Zheng, J. PY - 2011 DA - 2011// TI - Polymorphic structures of Alzheimer’s β-amyloid globulomers JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0020575 DO - 10.1371/journal.pone.0020575 ID - Yu2011 ER -